Prescribing biologics can require a complex approval and claims process. Creating a tiered system based on office workload can help practices understand and allocate staff time. Outsourcing approvals to pharmacies where possible can also streamline the process.
An alarming amount of COVID-19 disinformation is prevalent even from physicians.
Lifestyle behaviors, such as body mass index and smoking, were shown to have a stronger association with psoriasis, regardless of genetic risk.
Learning how to prescribe biologics, talking to mentors, reviewing journals, and getting involved in clinical trials are all ways to boost your expertise.
Doctors cite more support staff, reduced patient panels among solutions.
Dermatology Times® invites medical professionals in the dermatology community to speak out on the vital issues facing the specialty.
AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
Findings from a retrospective cohort study found that immune checkpoint inhibitors induced promising responses in the first- and second-line treatment of head and neck squamous cell carcinoma.
Expert insights on the latest issues in wounds as well as HS resources are shared at the annual meeting.
Research published in JAMA Dermatology finds dupilumab works quickly and safely for patients with erythrodermic atopic dermatitis.
By integrating capabilities and services, we can create health experiences that are much more than the sum of their parts.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
Drs Joshua Zeichner, MD, and Mona Gohara, MD, provide take-home messages to providers treating patients with acne.
CDC advises not to delay shingles vaccination.
More than 90% of respondents to a recent survey expressed concern about acne’s effect on their adolescent’s mental health and social life.
A 5-month-old girl with a large scalp infantile hemangioma (IH), present since 6 weeks of age, is evaluated in the emergency department for lethargy and pallor.
J.D. Norcross, director of information technology at VitalSkin Dermatology, discusses some myths and best practices with digital passwords you should know to help keep your practice information safer.
The FDA has approved the fixed-dose combination of relatlimab plus nivolumab for the treatment of adult and pediatric patients who are 12 years of age or older and who have unresectable or metastatic melanoma.
How will new federal law affect lives and wallets of physicians?